Venture-Backed Biotech Firm Raises $120M In Upsized IPO
Venture-backed oncology firm Oric Pharmaceuticals Inc. raised $120 million Thursday in an upsized initial public offering that priced at the top of its range, a strong sign in an otherwise tepid...To view the full article, register now.
Already a subscriber? Click here to view full article